Ghostboard pixel

πŸ’Š Health Futures #41

HolonIQ's Health Newsletter covers the latest developments in targeted chronic disease management, AI in health, and biotechnology and highlights the week's top skills and health deals.

πŸ’Š Health Futures #41


Happy Monday πŸ‘‹

OneOncology partners with Southeastern Medical Center allowing SMOC to offer patients access to high-quality cancer care services, including infusion therapy, clinical research, in-office drug dispensing, and laboratory services. Suki AI joined forces with Zoom Healthcare to integrate an AI assistant into their telehealth platform. In health funding, Roche withdrew a phase 1 trial of a MAGE-A4 T-cell bispecific marking this is the third program that Roche has withdrawn in the past year.A major health funding, Seaport Therapeutics secured $225M in Series B funding. The funding will be used to advance the development of its clinical-stage pipeline of neuropsychiatric medicines. In upskilling initiatives, The Federal Government's healthcare digitization plan aims to implement electronic health records in 1,691 facilities, targeting $3.3B in savings and 250,000 jobs across Africa by 2030.

🎯 Targeted Chronic Disease Management


πŸ’Š OneOncology partners with Southeastern Medical Center (SMOC) to enhance the delivery of cancer services in Eastern North Carolina. The partnership allows SMOC to join OneOncology’s physician-led oncology practice network, offering patients high-quality cancer treatments.

πŸŽ—οΈ Gilead Sciences plans to voluntarily withdraw the U.S. accelerated approval for metastatic urothelial cancer drug. The drug remains approved for other indications in the U.S. and is being evaluated in ongoing clinical trials for other types of cancer.

🩺 Avacta Therapeutics partners with Tempus AI. The partnership aims to advance the development of drugs in oncology and Avacta will gain access to Tempus datasets including samples of tumors of more than 200,000 patients across a range of cancer types.

🌐 AI in Health

πŸ€– Kakao Healthcare developed an AI-powered solution. Aiming to help patients with sugar disease manage their disease. The solution will use AI, digital, and mobile technologies to help patients manage their blood sugar levels and avoid hypoglycemic shock.

πŸ” Suki AI partners with Zoom Healthcare to integrate an AI assistant into Zoom's healthcare platform. This partnership will allow Zoom Healthcare to offer its users access to Suki's AI-powered clinical documentation and other features. 

βš•οΈ Aidoc partners with NVIDIA to develop a framework for the effective deployment and integration of AI tools. The BRIDGE guideline aims to help healthcare organizations scale AI innovation faster and more confidently.

🧬 Biotechnology

πŸ§ͺ Roche withdrew a phase 1 trial of a MAGE-A4 T-cell bispecific. Roche faced setbacks in its research and development of the MAGE-A4 therapies which could have implications for developing other MAGE-A4 therapies.

πŸ”¬ 23andMe faces financial difficulties raising concerns about the privacy of customer genetic data. Customers can take steps to protect their genetic data, such as reviewing the company's privacy policy and managing their data settings.

πŸ₯ J INTS BIO presented preclinical results for a second-generation synthetic inhibitor. The inhibitor could be a promising new treatment option for patients with drug-resistant ovarian cancer. 

πŸ› οΈ Skills and Workforce

With reskilling and upskilling playing a key role in closing workforce gaps, HolonIQ is now tracking these impactful initiatives shaping the health industry. Read on for this week’s insights.

🩺 The Federal Government has launched a roadmap to digitize healthcare, focusing on implementing electronic health records in 1,691 facilities nationwide. This shift aims to generate $3.3B in savings and 250,000 jobs across Africa by 2030. Experts, including World Bank and Healthcare Federation of Nigeria representatives, emphasize the potential for efficiency, emergency response, and access improvements through digital health solutions.

HolonIQ has also launched the Green Skills Map, an open-source framework initiated for the purpose of cataloging, evaluating, and contextualizing the different components of the rapidly expanding field of green jobs. This comprehensive taxonomy will serve as a resource for understanding the full spectrum and complexity of green skills required across various sectors, thereby enabling a cohesive approach toward achieving net zero and decarbonizing the global economy. Green Skills Map spans 11 areas, 54 sub-areas, and 243 green skills clusters. A snippet of the map covering four areas has been included above. Explore the full map on greenskills.org.

πŸ’° Deals of the Week

🦠 Seaport Therapeutics raised $225M in Series B funding which the funds will be used to advance its clinical stage pipeline of first and best-in-class medicines.

🧬 Triveni Bio completed a $115M Series B funding round. The funding will support the company's pipeline expansion, including the submission of an Investigational New Drug application for its lead candidate.

πŸ’‰ Purespring Therapeutics raised $96M in a Series B funding round. The funding will be used to accelerate the clinical progress of gene therapy for IgA Nephropathy.

🩹 Nuclera completed a $75M financing round to support the commercialization of its eProtein Discovery benchtop system enabling it to continue in the US and Europe.

🧫 Galileo raised $45M in Series B funding to scale its go-to-market strategy and expand its product development efforts. 


Thank you for reading. Have a great week ahead!
Have some feedback or suggestions? Let us know at hello@holoniq.com